Profile
DXR ISRG BDXA BDX RMD ALC
Company Name Daxor Corporation Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company ResMed Inc. Alcon Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $65.19M $160.63B $55.91B $53.65B $41.34B $37.85B
Employees 0.04K 15.64K 0.00K 70.00K 9.98K 25.60K
CEO Michael Richard Feldschuh Gary S. Guthart - Thomas E. Polen Jr. Michael J. Farrell BE, MBA, SM David J. Endicott
Ratings
DXR ISRG BDXA BDX RMD ALC
Quant Rating Score 3 3 5 3 4 3
Quant Rating Neutral Neutral Strong Buy Neutral Buy Neutral
Trading
DXR ISRG BDXA BDX RMD ALC
Last Close $13.0785 $448.09 $59.24 $193.93 $282.35 $76.55
High 52 $14 $610.45 $59.24 $249.08 $293.73 $98.3
Low 52 $7.05 $433.48 $59.24 $165.15 $204.58 $73.24
Price vs. 52 Week High -6.58 % -26.6 % 0 % -22.14 % -3.87 % -22.13 %
Price vs. 52 Week Low 85.51 % 3.37 % 0 % 17.43 % 38.01 % 4.52 %
Total Return
DXR ISRG BDXA BDX RMD ALC
1 Month Return 14.72 % -4.16 % 0 % 1.81 % 1.12 % -2.97 %
3 Month Return 37.67 % -15.1 % 0 % 10.5 % 10.4 % -11.99 %
6 Month Return 69.56 % -14.29 % 0 % -7.37 % 30.43 % -14.87 %
9 Month Return 64.2 % -17.63 % 0 % -17.28 % 19.55 % -8.55 %
YTD Return 70.07 % -14.15 % 0 % -14.52 % 23.46 % -9.82 %
1 Year Return 42.86 % -8.62 % 0 % -18.59 % 19.11 % -20.62 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DXR ISRG BDXA BDX RMD ALC
Dividend Yield Percentage (TTM) - - 2.17 % 2.22 % 0.78 % 0.44 %
Dividend Paid and Capex Coverage Ration (TTM) -35008 % 3.4 % 1.73 % 1.73 % 4.34 % 3.26 %
Dividend Per Share (TTM) - - 4.16 % 4.16 % 2.19 % 0.33 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 22.19 % 15.71 %
Profitability
DXR ISRG BDXA BDX RMD ALC
Gross Profit Margin TTM 89.54 % 66.65 % 45.08 % 45.08 % 59.36 % 55.13 %
Return on Assets TTM 5.01 % 12.93 % 2.93 % 2.93 % 17.14 % 3.42 %
Return on Equity TTM 5.03 % 15.57 % 6.31 % 6.31 % 25.51 % 4.93 %
Return on Capital Employed TTM 5.39 % 14.26 % 5.78 % 5.78 % 23.55 % 4.98 %
Net Income Per EBT TTM 100 % 87.46 % 83.91 % 83.91 % 83.5 % 85.57 %
EBT Per Ebit TTM 92.85 % 113.2 % 70.86 % 70.86 % 99.54 % 86.96 %
EBIT Per Revenue TTM 271.25 % 28.8 % 12.63 % 12.63 % 32.75 % 14.38 %
Cash Flow To Debt Ratio TTM -13.31 % - 16.82 % 16.82 % 198.52 % 39.27 %
Receivables Turnover TTM 393.63 6.56 7.27 7.27 5.48 4.98
Payables Turnover TTM 16.09 11.43 1.85 1.85 7.52 5.03
Inventory Turnover TTM - 1.83 2.97 2.97 2.25 1.88
Fixed Asset Turnover TTM - 183.44 % 313.67 % 313.67 % 716.47 % 197.54 %
Asset Turnover TTM 1.99 % 45.35 % 38.95 % 38.95 % 62.96 % 31.94 %
Operating Cash Flow Per Share TTM -0.01 7.88 11.3 11.3 11.96 4.16
Free Cash Flow Per Share TTM -0.01 5.56 8.85 8.85 11.32 3.23
Cash Per Share TTM - 1485.77 % 262.85 % 262.85 % 825.72 % 284.33 %
Operating Cash Flow Sales Ratio TTM -4.91 % 30.9 % 15.22 % 15.22 % 34.04 % 20.57 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.01 % 70.57 % 78.37 % 78.37 % 94.7 % 77.51 %
Cash Flow Coverage Ratios TTM -13.31 % - 16.82 % 16.82 % 198.52 % 39.27 %
Price To Free Cash Flows Ratio TTM -1861.96 80.54 21.58 21.04 24.92 23.68
Price To Operating Cash Flows Ratio TTM -1862.14 56.84 16.99 16.57 23.61 18.38
Price Cash Flow Ratio TTM -1862.14 56.84 16.99 16.57 23.61 18.38
Income Statement (TTM)
DXR ISRG BDXA BDX RMD ALC
Revenue $0B $8.35B $20.18B $20.18B $5.15B $9.91B
Gross Profit $0B $5.63B $9.13B $9.13B $3.05B $5.51B
Gross Profit Ratio 100% 67.46% 45.22% 45.22% 59.36% 55.61%
EBITDA $0B $2.81B $4.82B $4.82B $1.91B $2.68B
Net Income $0B $2.32B $1.71B $1.71B $1.4B $1.02B
EPS Diluted 0.11 6.42 5.86 5.86 9.51 2.05
Balance Sheet (MRQ)
DXR ISRG BDXA BDX RMD ALC
Long Term Debt $0B $0.11B $18.61B $18.61B $0.81B $4.97B
Total Liabilities $0B $2.31B $31.4B $31.4B $2.21B $8.79B
Total Equity $0.04B $16.53B $25.89B $25.89B $5.97B $21.55B
Total Investments $0.04B $7.05B $0.45B $0.45B $0.09B $0.91B
Total Debt $0B $0.15B $20.92B $20.92B $0.88B $5.14B
Total Assets $0.04B $18.84B $57.29B $57.29B $8.17B $30.35B
Cash Flow Statement (TTM)
DXR ISRG BDXA BDX RMD ALC
Net Income $0B $2.34B $1.71B $1.71B $1.4B $1.02B
Inventory $0B $-0.83B $0.1B $0.1B $-0.08B $-0.05B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.31B $-0.13B
Operating Cash Flow $0B $2.42B $3.8B $3.8B $1.75B $2.08B
Capital Expenditure $0B $-1.11B $-0.73B $-0.73B $-0.09B $-0.67B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 75.09
ANGO AngioDynamics, Inc. 11.18
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 132.545
ATRC AtriCure, Inc. 36.27
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 32.14
BAX Baxter International Inc. 22.86
BDX Becton, Dickinson and Company 190.06
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 14.455
BLFS BioLife Solutions, Inc. 27.69
COO The Cooper Companies, Inc. 70.16
EKSO Ekso Bionics Holdings, Inc. 5.2775
FEMY Femasys Inc. 0.6424
GCTK GlucoTrack, Inc. 8.1
ETFs With Exposure to DXR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00003 330.87
VTSAX Vanguard Total Stock Market Index Fund 0.00003 161.49
VITSX Vanguard Total Stock Market Index Fund 0.00003 161.52
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 502.2
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 302.98
Unlock